(TheNewswire)
Vancouver, British Columbia, Canada / TheNewswire / December 12, 2017 – Global Cannabis Applications
Corp. (“ GCAC ” or the “ Company ”) (CSE: APP, FSE:2FA, OTCQB: FUAPF), a leading developer of innovative data technologies for
the cannabis industry, is pleased to announce that it has entered into a strategic
partnership with SciCann Therapeutics, a pharmaceutical company based in Israel and Canada which
is
developing innovative cannabinoid based pharmaceuticals and therapies for a wide range of
debilitating ailments. SciCann was founded and is led by Dr. Zohar Koren, a world leading scientist in the study of novel and disruptive therapeutic products based on cannabinoids.
“I am impressed with the direction of GCAC’s medical cannabis data focus and, as practitioner in the
medical cannabis field, I see its long over due value,” said Dr. Zohar Koren, CEO of SciCann Therapeutics. “By combining our
scientific research and clinical data with GCAC technologies, we can deliver superior data outputs that can be used to provide
better medical cannabis products for patients around the world. The synergistic value and impact of combining our data and clinical
research tools together with GCAC’s artificial intelligence and blockchain environment is enormous.”
“I am delighted to be collaborating with Dr. Koren and SciCann Therapeutics with a history of
conducting important clinical studies on cannabinoids , ” said Brad Moore, CEO of
GCAC. “SciCann works on canna driven therapeutic products in the fields of
oncology, pain management, neurodegenerative diseases and inflammatory disorders, and will work in synergy with GCAC’s Pain to
Strain model. Our recent expansion into Lithuania’s blockchain community is reflective of our continued commitment to implement
real technology based solutions related to medical cannabis. We believe that the value of the partnership
with SciCann will be extremely beneficial to future development projects with licensed producers, canna product developers and
insurers, greatly adding to our revenue objectives.”
Dr. Koren holds a Ph.D. and M.Sc. in Computational Biology, both Magna Cum Laude, from the
University of Haifa, and a B.Sc. in Mathematics, Physics and Biology from the Hebrew University in Jerusalem. In 2012, he
co-founded Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a company focused on harnessing the therapeutic
properties of natural cannabinoid compounds, and served as Chief Executive Officer and Director. He served
as VP Business Development of Mor Research Applications – the commercial arm of Clalit Healthcare services, Israel’s largest health
organization that operates a network of 14 hospitals and has a annual turnover of over $6 billion. He has held senior executive
roles at several pharma companies including Aposense and Talent Biotechs. Dr. Koren has also provided strategic consulting services
for several leading Israeli venture capital firms specific to the pharmaceutical and medical device arena.
About Global Cannabis Applications Corp.
Global Cannabis Applications Corp. is a global leader in designing, developing, marketing, and
acquiring innovative data technologies for the cannabis industry. The Citizen Green platform is the world’s first end-to-end – from
patient to regulator – medical cannabis data solution. It uses six core technologies: mobile applications, artificial intelligence,
reg tech, smart databases, blockchain and digital reward tokens, to qualify candidates for clinical studies. These technologies
facilitate the proliferation of digital conversations by like-minded people in medical cannabis. Managed by digital and cannabis
industry experts, GCAC is focused on viral global expansion by providing the best digital experience in the cannabis market.
For more information about the Company, please visit online at www.cannappscorp.com , or review its profiles
www.sedar.com and on the Canadian Securities
Exchange’s website ( www.thecse.com ) .
To schedule an interview, please contact:
Bradley Moore
Chief Executive Officer
Telephone: 514-561-9091
Email: bmoore@cannappscorp.com
For more information, please contact:
Corporate Communications
Telephone: 1.855.269.9554
Email: info@cannappscorp.com
www.cannappscorp.com
Forward-Looking Information
This news release may include forward-looking information within the meaning of Canadian securities
legislation, concerning the business of GCAC. Forward-looking information is based on certain key expectations and
assumptions made by the management of GCAC. Although management of the Company believes that the expectations and assumptions
on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking
information because GCAC can give no assurance that they will prove to be correct. Forward-looking statements contained in
this news release are made as of the date of this news release. GCAC disclaims any intent or obligation to update publicly
any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as
required by applicable securities laws.
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the
adequacy and accuracy of this information.
Copyright (c) 2017 TheNewswire - All rights reserved.